Interleukin-23 Subunit p19
"Interleukin-23 Subunit p19" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A subunit of interleukin-23. It combines with INTERLEUKIN-12 SUBUNIT P40, which is shared between the two cytokines, to form in the active interleukin-23 cytokine.
Descriptor ID |
D053760
|
MeSH Number(s) |
D12.644.276.374.465.759.500 D12.776.467.374.465.759.500 D23.529.374.465.550.500
|
Concept/Terms |
Interleukin-23 Subunit p19- Interleukin-23 Subunit p19
- Interleukin 23 Subunit p19
- Interleukin-23 alpha Subunit
- Interleukin 23 alpha Subunit
- alpha Subunit, Interleukin-23
- IL-23p19
- IL-23 p19
|
Below are MeSH descriptors whose meaning is more general than "Interleukin-23 Subunit p19".
Below are MeSH descriptors whose meaning is more specific than "Interleukin-23 Subunit p19".
This graph shows the total number of publications written about "Interleukin-23 Subunit p19" by people in this website by year, and whether "Interleukin-23 Subunit p19" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Below are the most recent publications written about "Interleukin-23 Subunit p19" by people in Profiles.
-
Identification of CD37, cystatin A, and IL-23A gene expression in association with brain metastasis: analysis of a prospective trial. Int J Biol Markers. 2019 Mar; 34(1):90-97.
-
Downregulation of microRNA-107 in intestinal CD11c(+) myeloid cells in response to microbiota and proinflammatory cytokines increases IL-23p19 expression. Eur J Immunol. 2014 Mar; 44(3):673-82.
-
Immunological and antitumor effects of IL-23 as a cancer vaccine adjuvant. J Immunol. 2006 May 01; 176(9):5213-22.
-
Paradoxical anti-inflammatory actions of TNF-alpha: inhibition of IL-12 and IL-23 via TNF receptor 1 in macrophages and dendritic cells. J Immunol. 2005 Oct 15; 175(8):5024-33.
-
Role of IL-17A, IL-17F, and the IL-17 receptor in regulating growth-related oncogene-alpha and granulocyte colony-stimulating factor in bronchial epithelium: implications for airway inflammation in cystic fibrosis. J Immunol. 2005 Jul 01; 175(1):404-12.